Receptor Tyrosine Kinase inhibitors - Globe Thesis

Keyword [Receptor Tyrosine Kinase inhibitors] Result: 21 - 40 \| Page: 2 of 3
21.	Study Of ¹⁸F-FEA-erlotinib As An EGFR Targeting PET Imaging Agent
22.	Intercalated Combination Of Chemotherapy And EGFR-TKIs Versus Chemotherapy Alone In The First-line Treatment Of Advanced Non-small Cell Lung Cancer: A Meta-analysis
23.	Correlation Of EGFR Mutation With Brain Metastases In Non-small Cell Lung Cancer
24.	Role Of EMT In Radiosensitivity Of NSCLC With Acquired Resistance Of EGFR-TKI
25.	Efficacy And Safety Of Stereotactic Body Radiation Therapy In The Management Of Oligopersistent Disease In Patients With Egfr Mutant Non-small Cell Lung Cancer During EGFR-TKIs Treatment
26.	The Clinical Study And The Mechanism On The Reversion Of Acquired Resistance With The First Generation EGRF-TKIs For Advanced NSCLC Patients
27.	Proteomics In Non-Small Cell Lung Cancer Patients For Prediction Of Clinical Outcome After Treatment With Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors And Chemotherapy
28.	MiR-625-3p Modulates Gefitinib Resistance Through AXL In Non-small Cell Lung Cancer
29.	Clinical Study Of "Qing Xuan Fei Re Fa" On The Efficacy Of Skin Rash After Applying EGFR-TKI In Patients With Lung Cancer
30.	Study On EGFR-TKIs Resistance And BIN1 Expression In Lung Adenocarcinoma
31.	Clinical Outcomes Of Surgery Combined With Targeted Therapy In Non-Small Cell Lung Cancer
32.	Model To Predict PFS Of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors In Chinese Han Lung Adenocarcinoma Population
33.	Study On The Changes Of Plasma T790M Gene Mutation After TKI Therapy In Patients With Advanced Non-small Cell Lung Cancer
34.	Clinical Observation Of Xiao Zhen Tang On EGFR-TKIs Related Rash(Yin Deficiency Type) Of Lung Adenocarcinoma
35.	The Effect Of Concurrent TP53 Mutations On Clinical Efficacy Of First-generation EGFR-TKIs In Patients With EGFR-mutated Advanced NSCLC
36.	Design,Synthesis,and Anti-tumor Evaluation Of Novel Ureas As Vascular Endothelial Growth Factor-2 Receptor Tyrosine Kinase Inhibitors&Pyrrolic Compounds Construction
37.	The Relationship Between NLR & FIB And Prognosis Of Targeted Treatment In Advanced Lung Adenocarcinoma With EGFR Mutation
38.	A Retrospective Analysis Of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors (EGFR-TKIs) With Or Without Chemotherapy For Advanced Lung Adenocarcinoma
39.	MiR-206 Involved In Gefitinib Acquired Drug-resistance In Non-small Cell Lung Cancer Patients Through Modulating IL-6 Expression
40.	Clinical And Translational Study Of Delayed EGFR-TKI Acquired Resistance By Radiotherapy In Non-small-cell Lung Cancer
<<First <Prev Next> Last>> Jump to